58
Participants
Start Date
August 31, 2006
Primary Completion Date
September 30, 2010
Study Completion Date
September 30, 2010
Eszopiclone
Eszopiclone 3 mg po nightly for duration of study blind phase.
Placebo
Placebo nightly over duration of double blind study phase
Duke University Medical Center, Durham
Lead Sponsor
Sumitomo Pharma America, Inc.
INDUSTRY
Duke University
OTHER